NCT07047508View on ClinicalTrials.gov

Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 30, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Heart FailurePreserved Ejection Fraction
Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT07047508 - Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter